3 ms·

Reminds me of surgery teams trying to argue (with pre-/post-menopausal and trans women) that estrogen shouldn’t be taken before surgery because of the clotting

Reminds me of surgery teams trying to argue (with pre-/post-menopausal and trans women) that estrogen shouldn’t be taken before surgery because of the clotting risks — of a hormone that has simple coin-flip odds of being irreversibly present in their patients, and is also considered by many surgical teams to correlate with different clotting behaviors than men. (Not necessarily more clots, but certainly not the same ones they’re accustomed to.) Long-term, I expect the headline would likely be improved by stating instead: “NASA zero-gee sim reaffirms that women have different clotting behaviors than men” But selling that argument to U.S. researchers is an entire problem of its own; perhaps another presidential cycle.

katdork 8mo ago
as a trans woman, the clotting risk of estrogen proportional to levels is always cited to me by medical professionals when speaking about hrt, the risks, ... i've always found it kind of weird, like being told taking estrogen will cause "increased chance of breast cancer"; yeah, if you grow breasts, you will have more breast cells, more cell division, more chance for errors, no? but that's (at least partially) why i'm doing the whole thing to begin with...? :p and then they skimp on the doses... if this were statistically significant to such a degree that it truly mattered, women would not live longer than men on average. i feel like people get lost in the sheer stats of it
- altairprime 8mo ago
  The underlying summary is interesting. In women (whether or not trans), the synthetics increase clotting risk more than the bioidenticals do; and, separately, oral dosing pathways increase clotting risk more than liver-bypassing pathways (patch, gel, etc). I'd like to see more women asked by their surgical team to switch to transdermal patches before surgery rather than asked to stop taking their hormones. Recovery will be worse with preventable hormone imbalances, after all.

katdork 8mo ago

as a trans woman, the clotting risk of estrogen proportional to levels is always cited to me by medical professionals when speaking about hrt, the risks, ... i've always found it kind of weird, like being told taking estrogen will cause "increased chance of breast cancer"; yeah, if you grow breasts, you will have more breast cells, more cell division, more chance for errors, no? but that's (at least partially) why i'm doing the whole thing to begin with...? :p and then they skimp on the doses... if this were statistically significant to such a degree that it truly mattered, women would not live longer than men on average. i feel like people get lost in the sheer stats of it

altairprime 8mo ago
The underlying summary is interesting. In women (whether or not trans), the synthetics increase clotting risk more than the bioidenticals do; and, separately, oral dosing pathways increase clotting risk more than liver-bypassing pathways (patch, gel, etc). I'd like to see more women asked by their surgical team to switch to transdermal patches before surgery rather than asked to stop taking their hormones. Recovery will be worse with preventable hormone imbalances, after all.